1Wang W,Cassidy J,O'Brien V,et al.Mechanistic and Predictive Profiling of 5-Fluorouracil Resistance in Human Cancer Cells[J].Cancer Res 2004,64:8167-8176.
2Terashima M,Irinoda T,Fujiwara H,et al.Roles of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase in Tumor Progression and Sensifivity to 5-Fluorouracil in Human Gastric Cancer[J].Anticancer Res 2002,22:761-768.
3Nishina T,Hyodo I,Miyaike J,et al.The ratio of Thymidine Phosphorylase to Dihydropyrimidine Dehydrogenase in Tumour Tissues of Patients with Metastatic Gastric Cancer is Predictive of the Clinical Response to 5-DFUR[J].Eur J Cancer,2004,40(10):1566-1571.
5Garcia-Campelo R,Alonso-Curbera G,Anton Aparicio LM,et al.Pharmacogenomics in Lung caner:an Analysis of DNA Repair Gene Expression in Patients Treated with Platinunl-based Chemotherapy[J].Expert Opin Pharmacother,2005,6(12):2015-2026.
6Gossage L,Madhusudan S.Current Status of Excision Repair Cross Complementing-group 1 (ERCC1) in Cancer[J].Cancer Treat Rev,2007,33(6):565-77.
7Youn C K,Kim M H,Cho HJ,et al.Oncogenic H-Ras Up-regulates Expression of ERCC1 to Protect Cells from Platinum-based Anticancer Agents[J].Cancer Res,2004,64(14):4849-4857.
8Olaussen KA,Dunant A,Fouret P,et al.DNA Repair by ERCCl in Non-smail-cell Lung Cancer and Cisplatin-based Adjuvant Chemotherapy[J].N Engl J Med,2006,355(10):983-991.
9Ceppi P,Volante M,Novella s,et al.ERCCl and RRM1 Gene Expressions but not EGFR Ale Predictive of Shorter Survival in Advanced Non-small-cell Lung Cancer Treated with Cisplatin and Gemcitabine[J].Ann Oneol,2006,17(12):1818-1825.
